TipRanks
Hana Pharm Co., Ltd. (KR:293480)
:293480
South Korea Market
293480
Hana Pharm Co., Ltd.
RESEARCH TOOLSreports

Hana Pharm Co., Ltd. (293480) Ratios

― Followers

Hana Pharm Co., Ltd. Ratios

KR:293480's free cash flow for Q2 2026 was ₩0.60. For the 2026 fiscal year, KR:293480's free cash flow was decreased by ₩ and operating cash flow was ₩0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.96 1.84 3.33 1.82 2.32
Quick Ratio
 0.98 0.93 1.84 0.96 1.39
Cash Ratio
 0.19 0.15 0.27 0.03 0.28
Solvency Ratio
 0.26 0.19 0.40 0.43 0.40
Operating Cash Flow Ratio
 0.26 0.14 0.79 0.33 0.69
Short-Term Operating Cash Flow Coverage
 0.47 0.27 7.23 0.79 2.96
Net Current Asset Value
₩ 11.13B₩ 13.08B₩ 33.16B₩ 32.02B₩ 25.96B
Leverage Ratios
Debt-to-Assets Ratio
 0.15 0.14 0.08 0.08 0.10
Debt-to-Equity Ratio
 0.21 0.19 0.09 0.10 0.13
Debt-to-Capital Ratio
 0.17 0.16 0.09 0.09 0.11
Long-Term Debt-to-Capital Ratio
 0.09 0.07 0.07 <0.01 0.07
Financial Leverage Ratio
 1.35 1.33 1.24 1.25 1.29
Debt Service Coverage Ratio
 0.89 0.82 8.21 1.24 2.84
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 53.22
Debt to Market Cap
 0.46 0.28 0.14 0.10 0.10
Interest Debt Per Share
 3.88K 3.30K 1.68K 1.53K 2.01K
Net Debt to EBITDA
 1.36 1.32 0.63 0.72 0.57
Profitability Margins
Gross Profit Margin
61.46%61.12%62.70%62.19%62.24%
EBIT Margin
11.56%10.82%11.16%12.04%14.85%
EBITDA Margin
16.81%15.43%14.59%15.45%17.90%
Operating Profit Margin
11.56%10.82%11.16%12.04%14.78%
Pretax Profit Margin
11.34%7.67%11.27%12.43%14.57%
Net Profit Margin
7.06%3.67%9.43%9.95%11.53%
Continuous Operations Profit Margin
7.06%3.67%9.43%9.95%11.53%
Net Income Per EBT
62.29%47.76%83.68%80.03%79.13%
EBT Per EBIT
98.05%70.91%100.95%103.24%98.55%
Return on Assets (ROA)
3.91%2.10%5.56%6.41%7.03%
Return on Equity (ROE)
5.50%2.80%6.87%8.03%9.06%
Return on Capital Employed (ROCE)
7.48%7.32%7.18%9.25%10.35%
Return on Invested Capital (ROIC)
4.28%3.20%5.93%6.82%7.87%
Return on Tangible Assets
4.08%2.19%5.80%6.69%7.28%
Earnings Yield
11.97%4.40%11.27%8.98%7.89%
Efficiency Ratios
Receivables Turnover
 5.42 5.22 5.21 4.86 4.76
Payables Turnover
 4.31 13.79 12.63 13.16 9.87
Inventory Turnover
 1.52 1.60 1.77 1.76 1.92
Fixed Asset Turnover
 0.98 1.15 1.21 1.42 1.39
Asset Turnover
 0.55 0.57 0.59 0.64 0.61
Working Capital Turnover Ratio
 5.25 3.75 3.74 4.27 2.66
Cash Conversion Cycle
 223.51 271.12 247.15 255.27 229.57
Days of Sales Outstanding
 67.36 69.96 70.06 75.07 76.70
Days of Inventory Outstanding
 240.79 227.62 206.00 207.92 189.84
Days of Payables Outstanding
 84.63 26.46 28.91 27.73 36.97
Operating Cycle
 308.14 297.58 276.06 283.00 266.54
Cash Flow Ratios
Operating Cash Flow Per Share
 927.06 516.30 1.46K 1.06K 1.79K
Free Cash Flow Per Share
 -2.99K -1.12K 698.91 215.06 -282.56
CapEx Per Share
 3.92K 1.63K 763.51 848.80 2.07K
Free Cash Flow to Operating Cash Flow
 -3.23 -2.17 0.48 0.20 -0.16
Dividend Paid and CapEx Coverage Ratio
 0.22 0.24 1.15 0.78 0.69
Capital Expenditure Coverage Ratio
 0.24 0.32 1.92 1.25 0.86
Operating Cash Flow Coverage Ratio
 0.24 0.16 0.87 0.69 0.91
Operating Cash Flow to Sales Ratio
 0.07 0.04 0.11 0.08 0.15
Free Cash Flow Yield
-36.33%-9.96%6.41%1.50%-1.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 8.39 22.13 8.86 11.14 12.67
Price-to-Sales (P/S) Ratio
 0.59 0.83 0.84 1.11 1.46
Price-to-Book (P/B) Ratio
 0.44 0.64 0.61 0.89 1.15
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.76 -10.04 15.60 66.87 -63.00
Price-to-Operating Cash Flow Ratio
 8.90 21.73 7.45 13.52 9.97
Price-to-Earnings Growth (PEG) Ratio
 -0.57 -0.38 -1.89 -1.37 -0.78
Price-to-Fair Value
 0.44 0.64 0.61 0.89 1.15
Enterprise Value Multiple
 4.88 6.72 6.36 7.90 8.73
Enterprise Value
 202.33B 248.29B 209.17B 273.87B 329.47B
EV to EBITDA
 4.87 6.72 6.36 7.90 8.73
EV to Sales
 0.82 1.04 0.93 1.22 1.56
EV to Free Cash Flow
 -3.82 -12.50 17.30 73.61 -67.41
EV to Operating Cash Flow
 12.31 27.06 8.27 14.88 10.67
Tangible Book Value Per Share
 17.68K 16.62K 16.96K 15.24K 14.82K
Shareholders’ Equity Per Share
 18.72K 17.63K 17.87K 16.07K 15.52K
Tax and Other Ratios
Effective Tax Rate
 0.38 0.52 0.16 0.20 0.21
Revenue Per Share
 13.95K 13.48K 13.03K 12.98K 12.19K
Net Income Per Share
 985.40 493.90 1.23K 1.29K 1.41K
Tax Burden
 0.62 0.48 0.84 0.80 0.79
Interest Burden
 0.98 0.71 1.01 1.03 0.98
Research & Development to Revenue
 0.06 0.06 0.04 0.03 0.02
SG&A to Revenue
 0.29 0.24 0.25 0.25 0.23
Stock-Based Compensation to Revenue
 <0.01 0.00 0.00 0.00 0.00
Income Quality
 0.94 1.05 1.19 0.82 1.27
Currency in KRW